Kestra Medical Technologies, Ltd. Common Stock KMTS Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 48.8%+15.1pp | 46.4%— | 43.5%— | 40.5%— | |
| Operating margin | -171.5%-11.2pp | -174.3%— | -175.9%— | -177.8%— | |
| Net margin | -173%-0.8pp | -178%— | -180.3%— | -190.3%— | |
| EBITDA margin | -161.7%-19.6pp | -163.4%— | -164.5%— | -164.5%— | |
| Free cash flow margin | -142.9%+39.2pp | -152.9%— | -166.3%— | -168.1%— | |
| Liquidity | |||||
| Current ratio | 7.3×— | —— | —— | —— | |
| Quick ratio | 7.3×— | —— | —— | —— | |
| Cash ratio | 6.8×— | —— | —— | —— | |
| Leverage | |||||
| Debt-to-assets | 0.1×— | —— | —— | —— | |
| Interest coverage | -19.2×-8.7× | -17.6×— | -15×— | -13.8×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) runs a 48.8% gross margin and a -171.5% operating margin, with a -173.0% net margin.
- Where do Kestra Medical Technologies, Ltd. Common Stock's ratios come from?
- Every ratio is computed from Kestra Medical Technologies, Ltd. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
